New hope for long COVID sufferers: canadian trial tests treatments
NCT ID NCT05513560
First seen Feb 26, 2026 · Last updated May 06, 2026 · Updated 8 times
Summary
This Canadian study tested different treatments for people with lingering COVID-19 symptoms, known as Long COVID. About 460 adults with symptoms lasting at least 3 months were randomly assigned to one of two treatments or a placebo for 2 months, then followed for 4 more months. The goal was to see if these treatments could improve physical health and reduce bothersome symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mount Sinai Hospital
Toronto, Ontario, Canada
-
The Ottawa Hospital
Ottawa, Ontario, Canada
-
University Health Network, Osteoporosis Department
Toronto, Ontario, M5G 2C4, Canada
Conditions
Explore the condition pages connected to this study.